Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Alternatives to Laboratory Animals : ATLA|June 24, 2022
The Evolution of Regulatory Toxicology: Where is the Gardener?Robert Landsiedel, Barbara Birk, Dorothee Funk-WeyerThe Journal of Steroid Biochemistry and Molecular Biology|May 12, 2009
Selective aldosterone synthase inhibitors reduce aldosterone formation in vitro and in vivoChristina Ries, Simon Lucas, Ralf Heim, et al.Neurochemical Research|April 3, 2007
Thrombin causes the enrichment of rat brain primary cultures with ependymal cells via protease-activated receptor 1Felix Tritschler, Radovan Murín, Barbara Birk, et al.Journal of Medicinal Chemistry|December 4, 2008
In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-1H-quinolin-2-one derivativesSimon Lucas, Ralf Heim, Christina Ries, et al.Regulatory Toxicology and Pharmacology : RTP|March 19, 2025
Cross-taxa extrapolation: Is there a role for thyroid hormone conjugating liver enzymes during amphibian metamorphosis?Christel R Schopfer, Franziska Grözinger, Barbara Birk, et al.British Journal of Pharmacology|September 16, 2025
New biosensors and transgenic mice for multiplex cGMP imagingMarkus Wolters, Martin Thunemann, Barbara Birk, et al.ALTEX|March 15, 2018
Investigation of ruminant xenobiotic metabolism in a modified rumen simulation system (RUSITEC)Barbara Birk, Alexander Stähle, Mathias Meier, et al.Toxics|August 28, 2024
Limitations and Modifications of Skin Sensitization NAMs for Testing Inorganic NanomaterialsBritta Wareing, Ayse Aktalay Hippchen, Susanne N Kolle, et al.Chemico-Biological Interactions|October 18, 2021
The thyroid hormone converting enzyme human deiodinase 1 is inhibited by gold ions from inorganic salts, organic substances, and by small-size nanoparticlesAndreas Georg Weber, Barbara Birk, Chantal Müller, et al.Archives of Toxicology|December 16, 2018
In vitro-to-in vivo extrapolation (IVIVE) by PBTK modeling for animal-free risk assessment approaches of potential endocrine-disrupting compoundsEric Fabian, Caroline Gomes, Barbara Birk, et al.Pageof 3